agilon health, inc. (AGL) Return on equity 2021–2025
agilon health, inc. (AGL) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-308.8%FY2025 · since FY2021: -37.2% → -308.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -308.8% | -253.6 pp |
| FY2024 | -55.2% | -15.6 pp |
| FY2023 | -39.7% | -29.4 pp |
| FY2022 | -10.2% | +27.0 pp |
| FY2021 | -37.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice